Smart Thalassaemia Diagnostic System
IoT-enabled Testing Device AI-enabled Decision Suppport
Highest % of β-Thalassaemia
In south-East-Asian countries. Pakistan is one of the few with highest prevalence.
Huge Socio-economic burden
USD 203 Million approx. direct & indirect treatment cost per year per 100k patients (Pak).
0.5%–0.9% of all children deaths from LMICs
β-Thalassemia results in approx. 50,000–100,000 deaths annually around the globe.
Thalassaemia
Thalassaemia is an inherited blood-related disorder in which one or more globin chains are either not produced at all or are produced at a reduced rate.
Thalassaemia Minor
For a couple, if one of the partners carry the abnormal thalassaemia gene, there's a 50% risk of giving birth to 'Thalassaemia Minor' children.
Thalassaemia Major
For a couple, if both of the partners carry the abnormal thalassaemia gene, there's a 50% risk of giving birth to 'Thalassaemia Minor' children and 25% risk of giving birth to 'Thalassaemia Major' children.
Screening
In Pakistan, Punjab thalassaemia prevention program is active but the initiative hasn’t met the desired outcome. The screening devices are expensive, high maintenance and require expert handling. Diagnosis is expert-intensive and reports are often delayed with patients travelling from far areas to get tested.
Prevalence of Thalassaemia
250
Million Carriers
300000
New cases/year
10
Million Carriers
10000
New cases/year
Research
ThalaScreen is carrying out cutting-edge research in collaboration with expert haematologists to diagnose for Thalassaemia with advanced AI-algorithms. Our research objective is to prevent the spread of this national-level disease through an innovative digital thalassaemia diagnostic system.
Muhammad Salman Khan, Azmat ullah, Kaleem Nawaz Khan, Huma Riaz, Yasar Mehmood, Tawsifur Rehman, Muhmmad E.H. Chowdhury, “Automated Assessment of Thalassaemia from Haemoglobin Electrophoresis Images using Convolutional Neural Network”.
Patent filing in process, “Device, method and system for haemoglobin electrophoresis, automated image analysis and internet-of-things-enabled telepathology”.
AI-enabled
IoT-enabled
Portable
Easy Maintenance
Cloud Database
User-friendly
Collaborations
Our research collaborators include Khyber Medical College & University, Lady Reading Hospital, Hayatabad Medical Complex, KP Health Department, Rehman Medical Institute, Peshawar, Pakistan.
Team
ThalaScreen's team comprises of AI experts, biomedical, electronics and cloud engineers, software developers and haematologists.
Dr. Muhammad Salman Khan
FounderTraction
Incubation at NIC Peshawar
ThalaScreen got incubated in National Incubation Center, Peshawar in September of 2019 as a health-tech innovator after successful pitching sessions. During its period of incubation, the team has been able to understand multiple aspects of market research and business development.
GIST Startup Training
ThalaScreen was selected among only 20 startups from entire Pakistan for training under U.S Department of State’s Global Innovation through Science and Technology (GIST) Initiative. This bootcamp-styled training was very insightful in terms of refining our customer segments, customer channels and value propositions
Pakistan Startup Cup, 19
ThalaScreen has qualified first and second round of the Pakistan StartUp Cup 2019-20, landing among the top 12 startups from Peshawar, Pakistan.
ThalaScreen Declared as Health-tech Innovator
ThalaScreen is soon going to revolutionize the testing of thalassaemia helping thousands of patients particularly from far flung areas. ThalaScreen aims to develop a central database as a national repository for Thalassaemia minor population to facilitate targeted screening.
Contact
For any type of queries and/or pre-order requests, please contact with the information provided.
Email:
thalascreen@gmail.com
Call:
+92 316 9595140